HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Avon international sales advance 7% in second quarter 1996, pretax profits up 40%.

This article was originally published in The Rose Sheet

  • News

Executive Summary

AVON INTERNATIONAL SECOND QUARTER SALES ADVANCE 7% and pretax profits surged ahead 40%, the company announced July 25. The international growth reflected a strong performance in the Americas region (excluding the U.S.), growth in developing markets in Europe and the Pacific Rim and a favorable profit comparison reflecting one-time charges in Western Europe and Japan last year. Excluding the effect of the charges, international pretax profits rose 14% in the recent quarter

Table

View full table

Tags:
Latest Headlines

Supreme Court To Hear RICO Complaint Against CBD Firms As Hemp Regulation Remains AWOL

Nestlé Joins Forces With Dr Reddy’s In India To Grow Dietary Supplements Reach

Partisan Politics Returns To US FDA Congressional Oversight

The Aspirin Test For AI?

See All
UsernamePublicRestriction

Register

RS003028

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By